Overview


According to FutureWise analysis the market for blood group typing is expected to reach US$ 3.94 billion by 2031 at a CAGR of 9.32%.

Blood group typing is a medical procedure that is used to determine a person's blood type. Blood typing is important for a variety of reasons, including transfusions, pregnancy, and organ transplants. Blood typing involves identifying the presence of particular proteins, known as antigens, on the outermost layer of red blood cells. These antigens determine a person's blood type, which can be classified into several systems, the most commonly used of which are the ABO and the Rh systems. The ABO system is based on determining the occurance or absence of two antigens, A and B, on the exterior of red blood cells. The ABO system distinguishes four blood types: A, B, AB, and O. Individuals with blood type A have the A antigen on their red blood cells, while individuals who have blood type B have the B antigen. Individuals with blood type AB have both antigens, but those with type O blood have neither. The Rh system is based on the presence or absence of another antigen called the Rh factor. People with the Rh factor are classified as Rh-positive, while those without are Rh-negative.

Blood typing is important because incompatible blood transfusions can cause serious health problems, including kidney failure, shock, and even death. In addition, pregnancy complications can arise if a mother and fetus have different blood types, which can cause the mother's immune system to attack the fetus's red blood cells. Therefore, it is crucial to accurately determine a person's blood type before any medical procedures involving transferring blood or blood products.

FutureWise Market Research has published a report that provides an insightful analysis of Blood Group Typing Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Blood Group Typing Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Thermo Fisher Scientific
  • DIAGAST
  • Danaher Corporation
  • Immucor, inc.
  • Illumina, inc.
  • AXO Science
  • CareDx Inc.
  • Mesa Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Grifols
  • QIAGEN
  • Merck KGaA
  • Quotient, Ltd.
  • Day Medical SA

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Blood Group Typing Market:

  • In March 2022, The MosaiQ Extended Immunohematology (IH) microarray from Quotient Ltd was awarded the Conformité Européenne (CE) Certification.

The global blood group typing market is predicted to grow in the upcoming years due to the increasing demand for blood and blood products, the rising incidence of chronic diseases, and technological advancements in blood group typing. Blood group typing is essential for blood transfusions, organ transplantations, and pregnancy management. The market is also driven by increasing government initiatives to promote blood donation and increasing awareness about blood donation and transfusion. Additionally, the increasing number of blood banks and hospitals, especially in developing countries, is expected to contribute to the growth of the market. The availability of a wide range of blood group typing products, such as reagents, kits, and instruments, also drives market growth.

However, the high cost of advanced blood group typing tests and instruments makes them less accessible to patients and healthcare facilities in developing countries, where the need for blood transfusions is high. This, in turn, limits the market's growth potential in these regions. In addition, the regulatory requirements for blood group typing products are stringent, making it challenging for new entrants to enter the market. This could limit the competition in the market, leading to higher prices for consumers. Another challenge faced by the blood group typing market is the lack of skilled professionals trained to accurately perform blood group typing tests. This limits the availability of blood group typing services, especially in remote or rural areas, and can lead to delays in treatment and transfusions.

By Product And Service

  • Consumables
    • Antisera Reagents
    • Red Blood Cell Reagents
    • Anti-Human Globulin Reagents
    • Blood Bank Saline
  • Instruments
  • Services

By Technique

  • PCR-Based and Microarray Techniques
  • Assay-Based Techniques
  • Massively Parallel Sequencing
  • Other Techniques

By Test Type

  • Antibody Screening
  • HLA Typing
  • ABO Blood Tests
  • Cross-Matching Tests
  • Antigen Typing

By End User

  • Hospitals
  • Clinical Laboratories
  • Blood Banks
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the global market in 2022. The primary factors influencing the growth of the target market are an increase in traffic accidents and the prevalence of chronic disorders. In July 2022, According to the Association for Safe International Road Travel, the US was one of the countries with the most traffic, with almost 284 million cars on the road. Excessive traffic is one of the major factors causing traffic accidents. As a result, there is a rising need for blood group typing due to the rising number of traffic deaths and incidents. Over the course of the forecast period, this is anticipated to increase demand for the blood group typing market. Additionally, based on test type; the antibody screening is anticipated to grow at the highest CAGR over the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Blood Group Typing Market By Product And Service, By Technique, By Test Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Product Service launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Techniqueology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Blood Group Typing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Blood Group Typing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Blood Group Typing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Blood Group Typing Market,By Product And Service Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Consumables
         1.1. Antisera Reagents
         1.2. Red Blood Cell Reagents
         1.3. Anti-Human Globulin Reagents
         1.4. Blood Bank Saline
        2. Instruments
        3. Services

  • 8.   Global Blood Group Typing Market, By Technique Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. PCR-Based and Microarray Techniques
        2. Assay-Based Techniques
        3. Massively Parallel Sequencing
        4. Other Techniques

  • 9.   Global Blood Group Typing Market, By Test Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Antibody Screening
        2. HLA Typing
        3. ABO Blood Tests
        4. Cross-Matching Tests
        5. Antigen Typing

  • 10.   Global Blood Group Typing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinical Laboratories
        3. Blood Banks
        4. Other End Users

  • 11.   North America Blood Group Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Blood Group Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Blood Group Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Blood Group Typing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Services Offered and Financial Layouts)
    •      1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
           2. DIAGAST
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
           3. Danaher Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
           4. Immucor, inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
           5. Illumina, inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
           6. AXO Science
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
           7. CareDx Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
           8. Mesa Laboratories, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
           9. Bio-Rad Laboratories, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
           10. Grifols
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
           11. QIAGEN
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
           12. Merck KGaA
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
           13. Quotient, Ltd.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
           14. Day Medical SA
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients